Taiwan Insurers' FX Losses Double in May on US Dollar Slump
Taiwan's life insurers' foreign exchange losses more than doubled to a combined NT$263.8 billion ($9.1 billion) from January through May, as the US dollar's recent slide drove down the value of their foreign holdings.
Losses grew from NT$118.3 billion during January to April, according to a statement from the Financial Supervisory Commission in Taipei on Thursday. The industry's foreign exchange loss of NT$145.5 billion in May was the worst since the FSC started releasing the data in 2018, according to calculations by Bloomberg News.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
32 minutes ago
- Yahoo
Here's Riverwater Partners Small Cap Strategy's Investment Thesis for Bowhead Specialty Holdings (BOW)
Riverwater Partners, an investment management company, released its 'Small Cap Strategy' Q1 2025 investor letter. A copy of the letter can be downloaded here. The Small Cap Core Strategy outperformed the Russell 2000 in Q1 2025, driven by strong stock selection and sector allocation. Within this strategy, the firm focuses on bottom-up fundamental research rather than making top-down macroeconomic bets. While much of the market discourse today is centered on tariffs and U.S. fiscal policy, the firm's focus remains on identifying high-quality companies. In addition, you can check the fund's top 5 holdings to determine its best picks for 2025. In its first-quarter 2025 investor letter, Riverwater Partners Small Cap Strategy highlighted stocks such as Bowhead Specialty Holdings Inc. (NYSE:BOW). Bowhead Specialty Holdings Inc. (NYSE:BOW) is a specialty property and casualty insurance products provider. The one-month return of Bowhead Specialty Holdings Inc. (NYSE:BOW) was -0.85%, and its shares gained 48.57% of their value over the last 52 weeks. On June 27, 2025, Bowhead Specialty Holdings Inc. (NYSE:BOW) stock closed at $37.29 per share, with a market capitalization of $1.222 billion. Riverwater Partners Small Cap Strategy stated the following regarding Bowhead Specialty Holdings Inc. (NYSE:BOW) in its Q1 2025 investor letter: "Our interest in Bowhead Specialty Holdings Inc. (NYSE:BOW) stems from its strategic positioning in the attractive specialty insurance market, particularly within the Excess and Surplus (E&S) space. Their business model balances a "craft" approach for complex, individual risks with the newly launched "flow" business, Baleen, which targets smaller, hard-to-place risks using a tech-enabled platform. Critically, Bowhead leverages its strategic partnership with American Family (AmFam), utilizing AmFam's "A" rating, to help grow. An insurance agent at their desk consulting a customer about property & casualty insurance. Bowhead Specialty Holdings Inc. (NYSE:BOW) is not on our list of 30 Most Popular Stocks Among Hedge Funds. As per our database, 25 hedge fund portfolios held Bowhead Specialty Holdings Inc. (NYSE:BOW) at the end of the first quarter, which was 27 in the previous quarter. While we acknowledge the potential of Bowhead Specialty Holdings Inc. (NYSE:BOW) as an investment, our conviction lies in the belief that AI stocks hold greater promise for delivering higher returns, and doing so within a shorter timeframe. If you are looking for an AI stock that is as promising as NVIDIA but that trades at less than 5 times its earnings, check out our report about the undervalued AI stock set for massive gains. In another article, we covered Bowhead Specialty Holdings Inc. (NYSE:BOW) and shared Wasatch Micro-Cap Fund's views on the company. In addition, please check out our hedge fund investor letters Q1 2025 page for more investor letters from hedge funds and other leading investors. While we acknowledge the potential of BOW as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: The Best and Worst Dow Stocks for the Next 12 Months and 10 Unstoppable Stocks That Could Double Your Money. Disclosure: None. This article is originally published at Insider Monkey. Error while retrieving data Sign in to access your portfolio Error while retrieving data Error while retrieving data Error while retrieving data Error while retrieving data
Yahoo
43 minutes ago
- Yahoo
5 Revealing Analyst Questions From nLIGHT's Q1 Earnings Call
nLIGHT's first quarter was marked by robust revenue growth and a significant year-over-year improvement in profitability, with results exceeding Wall Street expectations and prompting a strong positive market reaction. Management attributed the outperformance to another quarter of record defense revenue, which accounted for over 63% of total sales, up from 49% a year ago. CEO Scott Keeney highlighted that 'the outperformance was primarily driven by another quarter of record defense revenue,' specifically citing strong momentum in directed energy and laser sensing programs for aerospace and defense customers. Sequential improvements in microfabrication, supported by stabilized operations at a Thai contract manufacturing partner, also contributed to the quarter. Is now the time to buy LASR? Find out in our full research report (it's free). Revenue: $51.67 million vs analyst estimates of $47.34 million (16% year-on-year growth, 9.1% beat) Adjusted EPS: -$0.04 vs analyst estimates of -$0.19 (78.7% beat) Adjusted EBITDA: $116,000 vs analyst estimates of -$5.14 million (0.2% margin, significant beat) Revenue Guidance for Q2 CY2025 is $56 million at the midpoint, above analyst estimates of $50.15 million EBITDA guidance for the full year is -$1.5 million at the midpoint, above analyst estimates of -$11.98 million Operating Margin: -18.6%, up from -33.1% in the same quarter last year Market Capitalization: $970.5 million While we enjoy listening to the management's commentary, our favorite part of earnings calls are the analyst questions. Those are unscripted and can often highlight topics that management teams would rather avoid or topics where the answer is complicated. Here is what has caught our attention. Jim Ricchiuti (Needham and Company) asked about the visibility for aerospace and defense product sales beyond Q2. CEO Scott Keeney responded that strong program pipelines and increased orders provide growing confidence, but broader economic uncertainties remain. Jim Ricchiuti (Needham and Company) also inquired about tariff impacts on different business segments. CFO Joe Corso explained that industrial fiber lasers are most exposed to tariff-related input cost increases, while defense is relatively insulated in the near term. Greg Palm (Craig Hallum) questioned what would be required to increase the full-year aerospace and defense revenue outlook. Keeney cited ongoing traction in both U.S. and international defense markets but pointed to tariff uncertainty as a limiting factor for guidance changes. Ruben Roy (Stifel) probed the company's approach to passing through increased costs from tariffs. Keeney described a mix of cost pass-through, production shifts, and regulatory mitigation, while Corso indicated that any widening of margin guidance is to reflect this uncertainty. Troy Jensen (Cantor Fitzgerald) asked about the sustainability of recent margin improvement and the significance of duty reclaim benefits. Corso clarified that while duty reclaim provided a one-time margin boost, future gross margins will depend on product mix and successful ramp-up in defense volumes. In the coming quarters, the StockStory team will be watching (1) continued ramp and delivery milestones for major defense programs like HEL-TD and DEM SHORAD, (2) the scale and timing of international defense contract wins, particularly with allies such as Israel, and (3) the extent to which nLIGHT can mitigate tariff-related cost pressures through supply chain adjustments. Progress in strengthening commercial market demand will also be a key indicator for broader business health. nLIGHT currently trades at $19.91, up from $8.60 just before the earnings. At this price, is it a buy or sell? See for yourself in our full research report (it's free). The market surged in 2024 and reached record highs after Donald Trump's presidential victory in November, but questions about new economic policies are adding much uncertainty for 2025. While the crowd speculates what might happen next, we're homing in on the companies that can succeed regardless of the political or macroeconomic environment. Put yourself in the driver's seat and build a durable portfolio by checking out our Top 6 Stocks for this week. This is a curated list of our High Quality stocks that have generated a market-beating return of 183% over the last five years (as of March 31st 2025). Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,545% between March 2020 and March 2025) as well as under-the-radar businesses like the once-small-cap company Comfort Systems (+782% five-year return). Find your next big winner with StockStory today. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
43 minutes ago
- Yahoo
Hamilton Insurance Group (NYSE:HG) Q1 Earnings: Leading The Reinsurance Pack
The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let's take a look at how reinsurance stocks fared in Q1, starting with Hamilton Insurance Group (NYSE:HG). This is a cyclical industry, and the sector benefits when there is 'hard market', characterized by strong premium rate increases that outpace loss and cost inflation, resulting in robust underwriting margins. The opposite is true in a 'soft market'. Interest rates also matter, as they determine the yields earned on fixed-income portfolios. The primary headwind remains the immense and concentrated exposure to large-scale catastrophe losses, as the growing impact of climate change challenges traditional risk models and creates significant earnings volatility. Additionally, they face the risk of adverse prior-year reserve development, where claims prove more costly than anticipated, while the eventual influx of new capital from alternative sources threatens to soften the market and compress future returns. The 7 reinsurance stocks we track reported a mixed Q1. As a group, revenues beat analysts' consensus estimates by 4.9%. In light of this news, share prices of the companies have held steady. On average, they are relatively unchanged since the latest earnings results. Founded in 2013 and operating through three distinct underwriting platforms across four countries, Hamilton Insurance Group (NYSE:HG) operates global specialty insurance and reinsurance platforms across Lloyd's, Ireland, Bermuda, and the United States. Hamilton Insurance Group reported revenues of $768.8 million, up 16.7% year on year. This print exceeded analysts' expectations by 28.3%. Overall, it was an exceptional quarter for the company with an impressive beat of analysts' EPS and net premiums earned estimates. Hamilton Insurance Group scored the biggest analyst estimates beat of the whole group. Unsurprisingly, the stock is up 11.7% since reporting and currently trades at $21.44. Is now the time to buy Hamilton Insurance Group? Access our full analysis of the earnings results here, it's free. With roots dating back to 1995 and now operating across insurance markets on six continents, Arch Capital Group (NASDAQ:ACGL) provides specialty insurance, reinsurance, and mortgage insurance services worldwide through its three main business segments. Arch Capital Group reported revenues of $4.67 billion, up 18.6% year on year, outperforming analysts' expectations by 1%. The business had a strong quarter with a solid beat of analysts' net premiums earned estimates and an impressive beat of analysts' EPS estimates. Although it had a fine quarter compared its peers, the market seems unhappy with the results as the stock is down 4.7% since reporting. It currently trades at $90.32. Is now the time to buy Arch Capital Group? Access our full analysis of the earnings results here, it's free. Rebranded from Everest Re in 2023 to reflect its evolution beyond just reinsurance, Everest Group (NYSE:EG) underwrites property and casualty reinsurance and insurance worldwide, serving insurance companies, corporations, and other clients across six continents. Everest Group reported revenues of $4.26 billion, up 3.1% year on year, falling short of analysts' expectations by 4.2%. It was a disappointing quarter as it posted a significant miss of analysts' net premiums earned and EPS estimates. As expected, the stock is down 2.3% since the results and currently trades at $336.78. Read our full analysis of Everest Group's results here. Founded in Bermuda in 2014 and designed to adapt nimbly to evolving market conditions, Fidelis Insurance (NYSE:FIHL) is a global specialty insurer and reinsurer that provides customized coverage across property, specialty, and bespoke risk solutions. Fidelis Insurance reported revenues of $658.4 million, up 26.6% year on year. This print surpassed analysts' expectations by 5.5%. It was a strong quarter as it also logged a narrow beat of analysts' book value per share estimates. The stock is down 4.6% since reporting and currently trades at $16.27. Read our full, actionable report on Fidelis Insurance here, it's free. Operating behind the scenes of the insurance industry since 1973, Reinsurance Group of America (NYSE:RGA) provides life and health reinsurance services to insurance companies, helping them manage risk and meet regulatory requirements. Reinsurance Group of America reported revenues of $5.34 billion, down 17.5% year on year. This number lagged analysts' expectations by 2.9%. Taking a step back, it was a mixed quarter as it also logged an impressive beat of analysts' book value per share estimates but a significant miss of analysts' net premiums earned estimates. Reinsurance Group of America had the slowest revenue growth among its peers. The stock is down 1.1% since reporting and currently trades at $197.48. Read our full, actionable report on Reinsurance Group of America here, it's free. Thanks to the Fed's series of rate hikes in 2022 and 2023, inflation has cooled significantly from its post-pandemic highs, drawing closer to the 2% goal. This disinflation has occurred without severely impacting economic growth, suggesting the success of a soft landing. The stock market thrived in 2024, spurred by recent rate cuts (0.5% in September and 0.25% in November), and a notable surge followed Donald Trump's presidential election win in November, propelling indices to historic highs. Nonetheless, the outlook for 2025 remains clouded by potential trade policy changes and corporate tax discussions, which could impact business confidence and growth. The path forward holds both optimism and caution as new policies take shape. Want to invest in winners with rock-solid fundamentals? Check out our 9 Best Market-Beating Stocks and add them to your watchlist. These companies are poised for growth regardless of the political or macroeconomic climate. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
